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Abstract—Anxiety disorders are the most prevalent central
nervous system diseases imposing a high social burden to
our society. Emotional processing is particularly controlled
by GABA-ergic transmission in the amygdala. Using in situ
hybridization and immunohistochemistry we now investi-
gated changes in the expression of GABA synthesizing en-
zymes (GAD65 and GAD67), GABAA (1–5, 1–3, 1–2) and
ABAB receptor subunits (GBBR1, GBBR2) in amygdaloid
uclei of high anxiety-related behavior (HAB) mice in com-
arison to mice selected for normal anxiety-related behavior
NAB). Levels of GAD65 and GAD67 mRNAs and protein, as
ell as those of GABA were increased in the amygdala of
AB mice. Relative to NAB controls, mRNA expression of the
ABAA receptor subunits 1, 2 and 2 was specifically
increased in the basolateral amygdala of HAB mice while
transcription of 5 and 1 subunits was reduced in the cen-
ral and medial amygdala. On the protein level, increases in
2 and 2 subunit immunoreactivities were evident in the
basolateral amygdala of HAB mice. No change in GABAB
receptor expression was observed. These findings point to-
wards an imbalanced GABA-ergic neurotransmission in the
amygdala of HABmice. On the other hand, FosB, a marker for
neuronal activity, was increased in principal neurons of the
basolateral amygdala in HAB mice, reflecting activation of
excitatory neurons, possibly as a consequence of reduced
GABA-ergic tonic inhibition through 5 and 1 containing
eceptors. Ultimately these mechanismsmay lead to the com-
ensatory activation of GABA transmission, as indicated by
he increased expression of GAD65/67 in HAB mice.
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
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Open access under CC BY-NC-ND Anxiety disorders are the most prevalent disorders of the
central nervous system imposing a high social burden to
individuals as well as to the society (Andlin-Sobocki et al.,
2005). While physiological anxiety is essential for the sur-
vival under changing environmental conditions, persistent
generalized anxiety or exaggerated inappropriate fear are
pathological manifestations that severely reduce quality of
life (Belzung and Griebel, 2001; Norrholm and Ressler,
2009). Little is known, however, about the molecular mech-
anisms leading to anxiety-related conditions.
There is considerable evidence indicating a role of
altered GABA-ergic transmission in human anxiety disor-
ders (Millan, 2003). Thus, benzodiazepines acting through
GABAA receptors are among the most widely prescribed
anxiolytic drugs (Nemeroff, 2003). Changes in GABAA re-
eptors were observed in limbic brain areas of panic dis-
rder patients by [14C]flumazenil positron emission tomog-
aphy (Hasler et al., 2008) and single nucleotide polymor-
hisms in the glutamate decarboxylase65 (GAD65) gene
ere associated with increased susceptibility to anxiety
isorders (Hettema et al., 2006).
GABA released from axon terminals can act on two
lasses of receptors, GABAA and GABAB receptors.
ABAA receptors are ligand-gated chloride channels (Ol-
en and Sieghart, 2009) consisting of five subunits derived
rom more than 15 different genes. Most GABAA receptors,
owever, consist of two -, two - and one - or -subunit
Sieghart and Sperk, 2002). The subunit composition de-
ermines the physiological and pharmacological properties
f individual receptor subtypes. In particular 2- and 2-
subunits of the GABAA receptor have been implicated in
mediating the anxiolytic effects of benzodiazepines (Cres-
tani et al., 1999; Low et al., 2000; Morris et al., 2006).
GABAB receptors are G-protein coupled, inhibitory re-
ceptors that are generally formed by heteromeric assembly
of two receptor molecules, one GABAB1 (GBBR1) with a
ABAB2 (GBBR2) subunit (Ulrich and Bettler, 2007).
ABAB receptors may also play a role in the integration of
anxiety, since mice deficient in GABAB receptors (GBBR1
r GBBR2) are more anxious in several behavioral para-
igms (Mombereau et al., 2004, 2005).
The GABA-ergic system in the amygdala does not only
odulate fear and anxiety under physiological conditions,
ut alterations in this system may also predispose individ-
als to pathological anxiety traits (Shen et al., 2010). The
im of our present study was therefore to elucidate the role
f the GABA-erigc system in anxiety-related behavior in
AB and NAB mouse lines. These two mouse lines ex-
ressing either high (HAB) or normal (NAB) levels of in-
orn anxiety-related behavior were selected by breeding
license.
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R. O. Tasan et al. / Neuroscience 183 (2011) 71–8072according to their anxiety-related behavior displayed on
the elevated plus maze (EPM) (Kromer et al., 2005). The
amygdala has a key role in the altered phenotypes of HAB
mice, since mild emotional challenge of HAB mice results
in differential activation of the amygdala and other brain
areas (Muigg et al., 2009). We performed in situ hybridiza-
tion and immunohistochemistry for GABA synthesizing en-
zymes, glutamate decarboxylase 65 (GAD65) and 67
(GAD67), as well as for GABAA (1–5, 1–3, 1–2) and for
GABAB (GBBR1, GBBR2) receptor subunits in the
mygdala under conditions of chronically increased trait-
nxiety of HAB compared to NAB mice.
EXPERIMENTAL PROCEDURES
Animals
All procedures involving animals and animal care were conducted
in accordance with international laws and policies (EEC Council
Directive 86/609, OJ L 358, 1, December 12, 1987; Guide for the
Care and Use of Laboratory Animals, U.S. National Research
Council, 1996) and were approved by the Austrian Ministry of
Science. All effort was taken to minimize the number of animals
used and their suffering.
Experiments were carried out on adult male HAB (n20) and
NAB (n23) mice at 12–15 weeks of age bred in the animal
facilities of the Department of Pharmacology and Toxicology,
University of Innsbruck, Austria. As previously described in more
detail (Kromer et al., 2005; Muigg et al., 2009), the two lines were
derived from a Swiss CD-1 outbred population selectively inbred
for either high or normal anxiety-related behavior displayed on the
EPM, with HAB mice spending less than 15% of the testing time
on its open arms, compared with approximately 35% for NAB mice
with no overlapping between the lines. The high anxiety pheno-
type of HAB mice was confirmed in the light/dark test and ultra-
sonic vocalization, previously (Kromer et al., 2005). In the current
experiments the behavioral phenotype of each mouse was tested
by an EPM test at 7 weeks of age. Animals were housed under
standard laboratory conditions (12:12 h light/dark cycle with lights
on at 7:00) with food and water available ad libitum. Mice were
housed in groups of four to five animals per cage.
Histochemistry
Tissue preparation. In order to avoid detection of possible
Table 1. Oligonucleotide sequence for in situ hybridization
mRNA Access code Oligonuceotide sequ
1 NM_010250.3 5= CCT GGC TAA G
2 NM_008066.3 5= CAT CGG GAG C
3 NM_008067.3 5= GGC CAG ATT G
4 NM_010251.2 5= GGA TGT TTC TG
5 NM_176942.3 5= TTG GGA TGT TT
1 NM_008069.4 5= TGC CTG TCC A
2 NM_008070.3 5= ACT GTT TGA AG
3 NM_001038701.1 5= CTG TCT CCC A
1 NM_010252.4 5= GGG AAT GAG A
2 NM_008073.2 5= GGC AAT GCG A
ə NM_008072.1 5= GGC AAG GTC C
GAD65 NM_008078.2 5= CTC CAT CAC AC
GAD67 NM_008077.3 5= GCA GGT TCT T
GBBR1 NM_019439.3 5= AAG CCA CGG T
GBBR2 NM_001081141.1 5= GAT GTA TGT Gimmediate changes of gene expression due to acute stress expo-sure of the mice during EPM testing, examination of the
GABA-ergic system was performed 4 weeks after behavioral ex-
periments. Mice were killed by carbon dioxide gas inhalation or by
injecting an overdose of thiopental (Thiopental, Sandoz, Austria)
for in situ hybridization and immunohistochemistry, respectively.
Brains were either snap frozen (isopentane, 70 °C, 3 min) for in
situ hybridization or perfused with 4% paraformaldehyde (PFA) for
immunohistochemistry (Tasan et al., 2010). Using a cryostat,
coronal sections of 20 m and 40 m were cut for in situ hybrid-
ization and immunohistochemistry, respectively. Every seventh
section was Nissl stained and series of matching sections were
selected for subsequent histochemistry.
In situ hybridization. In situ hybridization was performed as
described previously in detail (Tsunashima et al., 1997; Tasan et
al., 2010). Oligonucleotide probes targeting diverse markers of the
GABA-ergic system are listed in Table 1. They were custom
synthesized (Microsynth, Balgach, Switzerland, purified by
HPLC). Oligonucleotides (2.5 pmol) were 3= end-labeled by incu-
bation with [35S]-dATP (50 Ci; 1300 Ci/mmol, Hartmann Ana-
lytic GmbH, Braunschweig, Germany) and terminal transferase
(Roche Diagnostics, Basel, Switzerland), as described previously
in detail (Tsunashima et al., 1997). Hybridization was performed in
50% formamide, 4 SSC (1 SSC is 150 mM NaCl, 15 mM
sodium citrate, pH 7.2), 500 g/ml salmon sperm DNA, 250 g/ml
yeast tRNA, 1 Denhardt’s solution (0.02% Ficoll, 0.02% polyvi-
nylpyrrolidone, and 0.02% bovine serum albumin), 10% dextran
sulfate, and 20 mM dithiothreitol (all from Sigma) at 42 °C for 18 h.
The slides were washed at stringent conditions (50% formamide in
2 SSC, 42 °C) and briefly rinsed in water followed by 70%
ethanol, and dried. Slides were exposed to BioMax MR films
(Amersham Pharmacia Biotech, Buckinghamshire, UK) together
with [14C]-microscales for 7–14 days. For evaluation of the hybrid-
zation signal at the cellular level, some slides were dipped in
odak NTB-2 photosensitive emulsion (Kodak, Rochester, NY,
SA; diluted 1:1 with distilled water) at 42 °C, air dried over night,
nd then exposed for 4–6 weeks at 4 °C. The BioMax MR films
nd the dipped slides were developed with Kodak D19 developer.
ections were counterstained with Cresyl Violet, dehydrated,
leared in butyl acetate, and covered with a coverslip using Eukitt
Merck, Darmstadt, Germany).
Quantitative evaluation of in situ hybridization was done using
digitized images of the autoradiographs (eight bit digitized picture,
256 gray values). Gray values were measured by the public
domain program ImageJ 1.38x (NIH, USA; 255white; 0black)
and converted to relative optical density (ROD). ROD values
GGT ATA GCT GGT TGC TGT AGG AGC ATA TGT 3=
GAA CGG AGT CAG AAG CAT TGT AAG TCC 3=
ATA GGT GGT ACC CAC TAT GTT GAA GGT GGT G 3=
TTT CTC CTT CAG CAC AGG AGC AGC TGG 3=
GAT GGG TCA GCT TTC CAG TTG T 3=
CGC CCG AAG CCC TCG CGG CTG CTC AGT GG 3=
ATC CAG TCC TTG CTT CTC ACG GAA GGC TG 3=
CGC CCA TGC CCT TCC TTG GGC ATG CTC TGT 3=
TCC AGC ATG GAG ACC TGG GGA 3=
TAT CCT CCC ATG TCT CCA GGC TCC TGT TCG GC 3=
ACA GGC CAC TGT GGA GGT GAT GCG GAT GCT GTA T 3=
GCA GGT CTG TTG CGT GCA G 3=
ACT GCC TCT CCC TGA AGG CGC TCA C 3=
ATG CCA CCT TCC CAG GGC GGA TGT ATA ATC TGG C 3=
CTC TGG TGT GTC TTG TAG CTG CAT GGT GAC TTC TTC C 3=ence
TT AGG
AA CCT
AT AGG
T GTG
G GAG
GC CCA
A GGA
TG TAC
GT GGA
AT ATG
AT GTC
G CTG
GG AGG
AC CTGobtained from autoradiographic images were plotted against stan-
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R. O. Tasan et al. / Neuroscience 183 (2011) 71–80 73dard curves obtained from images of [14C]-microscales exposed
o the same film to insure that signal values are within the linear
ange of radioactivity, and then converted to percentage of control.
ach value was obtained from the innermost 90% of the respec-
ive brain area. Adjacent background levels with no hybridization
ignal (internal capsule) were obtained separately for each brain
ection and side. The anatomical level was verified in sections
ounterstained with Cresyl Violet using a mouse brain atlas
Franklin and Paxinos, 2007).
Immunohistochemistry. Immunohistochemical analysis
as performed on free-floating, PFA-fixed, 40 m thick coronal
ections using indirect peroxidase labeling, as described previ-
usly (Furtinger et al., 2001). The following antisera were used:
olyclonal rabbit anti-FosB (1:2000 SC-48; Santa Cruz Biotech-
ology), polyclonal rabbit anti-GABA (1:2000 A2052, Sigma),
onoclonal mouse anti-GAD67 (1:15,000 MAB 5406; Chemicon),
onoclonal mouse anti-CaMKII (1:5000 MAB, clone 6G9, Milli-
ore), polyclonal rabbit anti-2 subunit (1:100, residues 351–404)
nd polyclonal rabbit anti-2 subunit (1:300, residues 319–366)
(both gifts fromW. Sieghart, Vienna). A mouse Ig blocking reagent
(VECTOR® M.O.M. immundetection kit, Vector laboratories, Inc.,
Burlingame, USA) was used for monoclonal mouse antibodies
(GAD67, CaMKII). In brief, free floating coronal sections were
incubated in 10% normal goat serum (Biomedica, Vienna, Austria)
in Tris–HCl buffered saline (TBS; 50 mM, pH 7.2) for 90 min,
followed by incubation with primary antiserum. The resulting com-
plex was visualized by incubation with horseradish peroxidase-
coupled secondary antibody (1:250 P0448; Dako, Vienna, Austria)
at room temperature for 150 min. Sections were further incubated
in a solution containing 0.03% 3,3=-diaminobenzidine tetrahydro-
chloride (Sigma, St. Louis, MO, USA) and 0.005% H2O2 in TBS for
6 min. They were then mounted on slides, air-dried, dehydrated
and coverslipped. After each incubation step (with the exception of
preincubation with 10% normal goat serum), sections were
washed three times for 5 min each with TBS. All buffers and
antibody dilutions, except the buffer used for washing after per-
oxidase treatment and the diaminobenzidine reaction buffer, con-
tained 0.4% Triton X-100. Normal goat serum (10%) was included
in all buffers containing antibodies. In each experiment, sections
without primary antibody were included as a control. No immuno-
positive elements were detected in these control sections.
In addition, dual labeling of FosB with either CaMKII as
marker for pyramidal neurons or GAD67 as marker for non-pyra-
midal interneurons in the basolateral amygdala were performed to
determine the type of FosB expressing neurons. Sections were
incubated overnight at room temperature with rabbit anti-FosB
antibody (1:500, SC-48; Santa Cruz Biotechnology) together with
either a mouse monoclonal anti-CaMKII antibody (1:5000, Milli-
pore, Billerica, MA, USA) or with a mouse monoclonal anti-GAD67
antibody (1:20,000, Chemicon, USA). Sections were rinsed in
TBS-Triton (0.4%) and then incubated with a Vectastatin ABC-kit
(Mouse IgG, Vector laboratories, Inc., Burlingame, USA) and don-
key anti-rabbit Alexa Fluor 488 (1:500, Invitrogen, Eugene, USA)
for 60 min at room temperature. After washing in TBS, sections
were incubated in a tyramide amplification solution (1:100, TSA
Plus Cyanine 3 System, PerkinElmer, MA, USA) for 2 min,
mounted on slides and covered using Vectashield mounting me-
dium (Vector laboratories, Inc., Burlingame, USA).
Number of FosB, GAD67 and GABA immunoreactivity posi-
tive cells was obtained for each marker bilaterally from two
matched sections per animal (four NAB and four HAB mice) in the
basolateral amygdala (BLA) at a magnification of 400 times in
multiple separate fields and mean values were calculated for each
mouse. Results are presented as number of immunoreactivity
positive cells/mm2 and expressed as meanSEM.
Analysis of dual labeling immunofluorescence was done as
described elsewhere (McDonald and Mascagni, 2010). In brief,
two matched sections per animal (four NAB and four HAB mice)containing the BLA were processed for either FosB/CaMK or
FosB/GAD67 dual localization. Identification of dual labeled cells
was performed at 400 times magnification in multiple separate
fields within the BLA in each section.
Behavioral testing
Elevated plus maze. This test was used as a widely ac-
cepted test for anxiety-like behavior as described in detail previ-
ously (Lister, 1987; Tschenett et al., 2003).
Statistical analysis
Data are presented as meansSEM. Data were analyzed for
normal distribution and equal variances using GraphPad Prism
software (Prism 5 for Macintosh, GraphPad Software Inc., San
Diego, CA, USA). Statistical analysis of behavior was done by
Student’s t-test for data with normal distribution or Mann–Whitney
test as a nonparametric test. ANOVA was used to analyze overall
changes in percentage of mRNA ROD values in the CEA, BLA
and MEA of HAB and NAB mice, with a Bonferroni post hoc test
omparing HAB and NAB of the respective subregion. Linear
egression and a Spearman correlation were used to investigate a
orrelation between mRNA expression and anxiety-related pa-
ameters as well as locomotor-related parameters on the EPM at
weeks of age.
RESULTS
HAB mice (n20) showed a significantly reduced percent-
age of time spent in the open arms compared to NAB
controls (n23), (HAB: 5.20.89, NAB: 28.51.32,
P0.0001) and percentage of open arm entries (HAB:
21.12.11, NAB: 44.51.65, P0.0001), indicating in-
creased anxiety-related behavior and thus confirming the
extremely anxious phenotype of each HAB mouse on the
EPM. In addition, HAB mice exhibited reduced motor ac-
tivity under stressful conditions as reflected by a de-
creased number of closed arm entries (HAB: 23.31.66,
NAB: 33.91.53, P0.0001) and reduced total distance
traveled (HAB: 9.10.82 m, NAB: 14.30.46 m,
P0.0001) on the EPM during the 5 min testing period.
Histochemical results
Increased expression of GAD in the amygdala of HAB
mice. As shown in Fig. 1A, the mRNAs encoding for the
GABA synthesizing enzymes GAD67 and GAD65 (not
shown) were particularly concentrated in the central
amygdala (CEA) while their expression was lower both in
the medial (MEA) and basolateral nucleus of the amygdala
(BLA). In HAB mice, a pronounced up-regulation of mRNA
abundance of the GABA synthesizing enzymes GAD65
and GAD67 was evident in the amygdala (Fig. 1A, B, Table
2), but not in other brain regions, including the granule cell
layer of the dentate gyrus in the dorsal (% of control NAB:
100.07.00 and HAB: 107.06.15; P0.47, Student’s t-
test, meanSEM) (Fig. 1A, C) as well as in the ventral
hippocampus (% of control NAB: 100.06.07 and HAB:
85.47.09; P0.14, Student’s t-test, meanSEM). To in-
vestigate whether the increased mRNA expression trans-
lates into higher protein levels we performed immunohis-
tochemistry for GAD67 and GABA (Fig. 2). Indeed immu-
noreactivity for GAD67 (Fig. 2A, C) as well as for GABA
(Fig. 2B, C) was enhanced in the amygdala of HAB mice.
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R. O. Tasan et al. / Neuroscience 183 (2011) 71–8074Since increased GAD67 mRNA expression may be
aused by sustained neuronal activity due to chronically
nhanced stress levels, we performed immunohistochem-
stry for FosB, a marker of long-term adaptive changes in
he brain. The number of FosB positive cells was signifi-
antly higher in the BLA of HAB mice than of NAB controls
Fig. 3A, B). In both, HAB and NAB mice, FosB labeling
as co-localized with CaMKII labeling in the BLA (Fig. 3C),
ut was absent from GAD67 positive neurons (Fig. 3C),
ndicating chronic activation of principal neurons rather
han of interneurons.
Expression of mRNA and immunoreactivity of GABAA
and GABAB receptor subunits in the amygdala of NAB
mice. Control NAB mice revealed a similar distribution of
GABAA receptor subunit mRNAs in the amygdaloid nuclei
as previously described for C57BL/6J mice (Heldt and
Ressler, 2007a,b). High expression of GABAA receptor
subunit 2, 3, 3 and 2 mRNAs was observed in the
LA while GABAA receptor subunits 4 and 1 were mod-
erately and 1, 5, 2 and 1 subunit mRNAs only weakly
xpressed. In the CEA, there was a predominant expres-
ion of 2, 3, 3 and 2 mRNAs and a moderate expres-
ion of 1 and 1 subunit mRNAs. The MEA was charac-
terized by high expression of GABAA receptor subunit 2,
3, 1, 3, 1 and 2 mRNAs. Regarding GABAB recep-
tors, GBBR1 subunit mRNA was equally high expressed in
the BLA, CEA and MEA, whereas the mRNA for the GBBR
Fig. 1. Expression of GAD67 mRNA in HAB and NAB mice. (A) Film
AD67 mRNA in coronal sections of a HAB mouse brain compared to
mygdaloid complex of HAB mice, (B) increased expression of GAD67
EA and (C) in the somatosensory cortex (CXS), hilus of the dentate g
f GAD67 mRNA with percentage open arm time in HAB mice and (E
onferroni post hoc test, *** P0.001 (HAB n16, NAB n19); scale2 subunit was restricted mainly to the BLA and MEA.Altered expression of GABAA receptor subunits in the
amygdala of HAB mice. The expression profile of the
different GABAA receptor subunit mRNAs in the amygdala
f HAB mice was distinct from NAB controls. In HAB mice,
here was a significant increase of GABAA receptor subunit
1 mRNA in all amygdala nuclei investigated (Table 2). In
ddition, the percentage of 2 mRNA was higher in the
LA, but not in the CEA or MEA of HAB mice (Fig. 4E–H,
able 2). Among the -subunits only expression of 5
RNA was altered in the amygdala. Although basal levels
f 5 mRNA were already low throughout the amygdala of
NAB controls, they were further reduced in the CEA and
MEA of HAB mice (Table 2). Interestingly, in HAB mice the
1 mRNA levels were reduced in all amygdaloid nuclei
Fig. 4A–D, Table 2), whereas those of 2 mRNA were
specifically increased in the BLA and CEA (Table 2). As
shown in Fig. 5, 2 and 2 subunit immunoreactivities
were also clearly increased in the BLA of HAB mice.
No difference in the mRNA abundance of both GABAB
receptor subunits GBBR1 and GBBR2 was detected in any
of the amygdaloid nuclei of HAB mice compared to NAB
controls.
Correlation of GAD expression in the amygdala with
EPM behavior. To investigate whether increased expres-
sion of GADs may be associated with altered anxiety-like
and/or locomotor-related behavior, we performed a corre-
lational analysis of GAD67 and GAD65 mRNA levels with
iographs from in situ hybridization experiments displaying increased
trols, a higher magnification showing GAD67 mRNA expression in the
n coronal brain sections of HAB mice, quantified in the BLA, CEA and
) and dentate granule cell layer (GCL), (D) correlation of ROD values
ntrols. Values in (A) and (B) are meansSEM, one-way ANOVA with
0 m.autorad
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R. O. Tasan et al. / Neuroscience 183 (2011) 71–80 75open arm time and total distance traveled). Indeed, the
expression of GAD67 mRNA in the BLA of HAB mice, was
positively correlated with the percentage of open arm time
(r0.58, P0.019; Fig. 1D), but not with the total distance
raveled by the mice (r0.40, P0.139). In contrast, no
orrelation of GAD67 mRNA levels with percentage open
rm time (r0.21, P0.383; Fig. 1E) or total distance
traveled (r0.005, P0.983) was observed in NABmice.
These findings imply that the up-regulation of the GAD67
may be a compensatory reaction to the high anxiety be-
havior phenotype of HAB mice. In contrast, when we in-
cluded both groups, HAB and NAB mice, into the analysis
there was a negative correlation of GAD65 and GAD67
mRNAs expression in all amygdaloid nuclei (BLA, CEA
and MEA) with both, anxiety-like and locomotor-related
behavior on the EPM (data not shown). These findings
were not surprising, since they reflect largely the differ-
ences in the preselected phenotypes.
Altered GABAA receptor subunit mRNA expression
correlated with anxiety- and motor activity-related behavior
when both groups, HAB and NAB mice, were included.
There was no correlation, however, at the level of the
individual groups (not shown).
DISCUSSION
The present study identified prominent changes of the
GABA system in the amygdala of HAB mice, an animal
model of increased trait anxiety. These include markedly
increased expression of the GABA synthesizing enzymes
GAD65 and GAD67 together with increased expression of
GABAA receptor subunit 1, 2, 2 mRNAs, whereas sub-
nit 5 and 1 mRNA levels were decreased.
In the BLA, most non-pyramidal neurons use GABA as
principal neurotransmitter and exert an inhibitory action
n glutamatergic principal cells (Pare et al., 2003). This
nhibition is predominantly generated through GABAA re-
ceptors that mediate either a phasic response when lo-
cated within the synapse or maintain tonic inhibition at
extrasynaptic sites (Semyanov et al., 2003, 2004). Spon-
taneous firing rates in the lateral and central amygdala are
among the lowest in the brain, indicating potent tonic inhi-
bition suppressing neuronal activity in the amygdala (Quirk
and Gehlert, 2003). On the other hand, repeated stimula-
tion of the BLA, leads to long-term synaptic facilitation and
a behavioral state of chronic anxiety (Sajdyk and Shekhar,
2000).
GABA synthesizing enzymes (GAD65 and GAD67)
GAD65 and GAD67 are catalyzing GABA synthesis and
their activity is tightly related to the tone of GABA neurons.
They are abundantly expressed in the amygdala (Fig. 1A).
In the BLA both enzymes are primarily expressed in in-
terneurons (McDonald and Pearson, 1989) whereas in the
CEA they are also contained in GABA-ergic projection
neurons targeting forebrain and brain stem areas (LeDoux
et al., 1988; Bourgeais et al., 2001). Impaired GABA-ergic
transmission in GAD65 knockout mice results in increased
anxiety-related behavior in the open field and elevatedTa
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rR. O. Tasan et al. / Neuroscience 183 (2011) 71–8076zero maze (Kash et al., 1999). Considerable evidence
suggests that increased GABA-ergic transmission in the
BLA is associated with reduced anxiety, while increasing
the excitability of BLA projection neurons by inhibition of
GABA transmission tends to be anxiogenic (Davis et al.,
1994; Shekhar et al., 2003). In contrast, the high anxiety
level in HAB mice is associated with an increased expres-
sion of GAD65 and GAD67. This increase in GABA syn-
thesis may be part of a compensatory mechanism balanc-
ing the persistent over-stimulation of limbic brain areas, as
indicated by the positive correlation of GAD mRNA expres-
Fig. 2. GAD67 and GABA immunoreactivity (IR) in the amygdala of HA
sections demonstrating GAD67-IR labeling in the amygdala of HAB
positive cells in the BLA of HAB mice compared to NAB controls, (B)
sections demonstrating an increased number of GABA-IR positive cells
cells in the BLA of HAB and NABmice. Arrows in (A) and (B) depict GAD
in (C) are meansSEM, Mann–Whitney test, * P0.05; ** P0.01 (H
50 m.
Fig. 3. FosB immunoreactivity in the BLA of HAB and NAB mice. (A
sections showing FosB positive cells in the BLA of NAB and HAB mic
the BLA of HAB mice, (C) dual labeling immunofluorescence reveals
GAD67-IR in the BLA, arrows in (C) show CaMKII positive and GAD67
* P0.05 (HAB n4, NAB n4), scale bars: (A) 50 m, (C) 10 m.
eferred to the Web version of this article.sion with percentage open arm time. The increased ex-
pression of GADs may be driven by a sustained activation
of the amygdala in HAB mice. On the other hand recent
evidence suggests also excitatory actions of GABA in the
basal amygdala (Woodruff et al., 2006), resulting in rapid
activation of basolateral pyramidal neurons that may sig-
nificantly contribute to increased anxiety-related behavior.
Activation of amygdala nuclei in response to stress has
been well documented by increased expression of imme-
diate early genes c-Fos and Zif-268 (Hoffman and Lyo,
2002; Singewald, 2007; Kovacs, 2008) and has also been
AB mice. (A) Bright field photomicrographs of representative, matched
mice, higher magnification depicts increased number of GAD67-IR
d photomicrographs of GABA-IR labeling on representative, matched
A of HAB mice, (C) quantification of GAD67-IR and GABA-IR positive
d GABA-IR positive cells in the BLA of NABmice, respectively. Values
NAB n4), scale bars: low magnification 500 m, high magnification
agnification, bright field photomicrograph of representative, matched
antification demonstrating increased number of FosB positive cells in
zation of FosB (green) staining with (red) CaMKII but not with (red)
ells, respectively. Values in (B) are meansSEM, Mann–Whitney test,
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R. O. Tasan et al. / Neuroscience 183 (2011) 71–80 77demonstrated in limbic areas of HAB mice (Muigg et al.,
2009). Recently, Carta et al. (2008) reported increased
expression of GAD67 mRNA in the CEA in response to
stressful stimuli, reflecting long-term changes in neuronal
activity (Carta et al., 2008). In the present study, the pro-
nounced increases of GAD65 and GAD67 mRNAs in the
amygdala of HAB mice may reflect chronic activation in
amygdala nuclei due to consistently higher stress levels in
these mice. This is supported by the increase in FosB-
positive principal (glutamatergic) neurons in the BLA of
HAB mice indicating chronic activation of the amygdala in
the highly anxious HAB line already under baseline, non-
stressful conditions.
This idea is further supported by a study in rats dem-
onstrating that low exploratory activity on the EPM is as-
sociated with increased expression of GAD65/67 mRNA in
the amygdala (Nelovkov et al., 2006). Notably, low explor-
atory behavior, besides reduced general motor activity
may be related to increased anxiety, particularly when
displayed in stressful situations like EPM exposure
(Nelovkov et al., 2006). Our correlation analysis revealed
lower anxiety in HAB mice correlating with high GAD67
mRNA levels (Fig. 1D). While this correlation provides
informative evidence, further experiments, however, are
needed to obtain a clear causal relationship between an
altered GABA-ergic system and anxiety-related behavior in
these mice.
GABAA receptor  subunits
Receptors containing the 5 subunit are often located
extrasynaptically, predominantly mediating tonic inhibition
(Scimemi et al., 2005; Zarnowska et al., 2009). Mice with
reduced expression of 5 subunit in the hippocampus
display facilitated trace fear conditioning, a special form of
associative learning that requires hippocampal processing
(Crestani et al., 2002). Although most of the investigations
Fig. 4. GABAA receptor subunit mRNAs in the amygdala of HAB and
of GABAA receptor 1 subunit mRNA in the amygdala of HAB (BD
expression of 1 subunit mRNA in the amygdala of a HAB mouse, (E
hybridization demonstrating increased 2 mRNA in the BLA of HAB
increased expression of 2 mRNA in the BLA of a HAB mouse. Scale b
n this figure legend, the reader is referred to the Web version of thison 5 subunits have been performed in the hippocampus,similar yet more anxiety-related role may be integrated in
he amygdala. Since HAB mice displayed a decreased
bundance of 5 subunit mRNAs in the CEA and MEA, a
educed inhibitory tonus in the amygdala of HAB mice may
acilitate emotional activation and propagate a behavioral
tate of enhanced trait anxiety. Indeed, over-excitation
fter mild emotional challenge has been demonstrated
ecently in the amygdala of HAB compared to NAB mice
Muigg et al., 2009).
ABAA receptor  subunits
Given that  subunits contain part of the binding pocket for
ABA, any change in their expression level is of physio-
ogical significance. In situ hybridization experiments indi-
ate an increase of 1 subunit mRNA in all amygdaloid
uclei investigated (BLA, CEA and MEA) and a selective
ncrease of 2 mRNA restricted to the BLA of HAB mice
(Table 2). Recently, Heldt et al. (2007a) demonstrated an
up-regulation of 2 subunit in the amygdala after fear
onditioning in mice after unpaired tone-shock exposure.
hey speculated that this reflected a state of hyperexcit-
bility, similar to increased expression levels of  subunits
een in seizure-evoked animal models of epilepsy (Tsu-
ashima et al., 1997; Pirker et al., 2003; Nishimura et al.,
005). Therefore also in HAB mice the selective increase
n 2 subunit mRNA may be due to over-excitation of the
LA as indicated by increased number of FosB positive
eurons under baseline conditions.
ABAA receptor  subunits
In HAB mice, we observed a reduction of the 1 subunit
mRNA levels in all amygdaloid nuclei investigated (Ta-
ble 2), whereas those of the 2 subunit were increased
pecifically in the BLA and CEA (Table 2). The mRNA
levels for the  subunit were below detection limit in the
mygdala. The 2 subunit mediates postsynaptic clus-
. (AB) Film autoradiographs and (CD) pseudocolor coded images
AB mice (AC) are shown, arrows in (B) and (D) indicate reduced
autoradiographs and (GH) pseudocolor coded images of an in situ
H) compared to NAB controls (EG), arrows in (F) and (H) indicate
) 500 m; (E–H) 500 m. For interpretation of the references to colorNAB mice
) and N
F) film
mice (F
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R. O. Tasan et al. / Neuroscience 183 (2011) 71–8078(Crestani et al., 1999). Knockout mice, heterozygous for
the 2 subunit, display increased anxiety-related behav-
or and reduced benzodiazepine binding sites. Although
he total number of GABAA receptors is not altered,
ynaptic clustering is significantly reduced (Crestani et
l., 1999). The increased expression of the 2 subunit
RNA in HAB mice may reflect an accelerated turnover
f the 2 subunit containing GABAA receptors due to
hronically high stress conditions and may indicate a
ompensatory mechanism counteracting increased
mygdala activity. Following EPM exposure, Chacur et
l. (1999) observed increased [3H]-flunitrazepam but not
3H]-muscimol binding specifically in the CEA and BLA,
ndicating a higher sensitivity of GABAA receptors to
benzodiazepines although the total number of receptors
may not be altered (Chacur et al., 1999).
Increased sensitivity to the anxiolytic effect of diaz-
epam is generally observed in rodents with low explor-
ative activity and changes in the subunit composition of
Fig. 5. Immunoreactivities for GABAA receptor 2 and 2 subunits in
the basolateral amygdala (BLA) of HAB and NAB mice. (A) Bright field
photomicrographs of representative, matched sections demonstrating
2 subunit-IR labeling and (B) 2 subunit-IR labeling in the BLA of
HAB and NAB mice. Arrows indicate IR in the BLA. Note the increased
labeling of the BLA compared to the lateral amygdala (LA) in HAB
mice. BMA, basomedial amygdala. Scale bar: 500 m.GABAA receptors due to altered subunit expression maye an attractive explanation for this phenomenon
Liebsch et al., 1998; Bert et al., 2001; Nelovkov et al.,
006). In the present study, also HAB mice exhibit low
xplorative activity during EPM stress, presumably re-
ated to the high trait anxiety of these mice. Thus, the
igh sensitivity of HAB mice to the anxiolytic effect of
enzodiazepines (Kromer et al., 2005) may, at least in
art, be related to the higher number of 2 containing
GABAA receptors, known to mediate the action of ben-
odiazepines in the amygdala.
Interestingly, whereas 2 subunits are increased in the
amygdala of HAB mice, 1 subunits, particularly enriched
in the CEA and MEA, are significantly reduced in these
mice (Table 2). Esmaeili et al. (2009) recently demon-
trated that GABA-ergic synapses formed by lateral inputs
o the CEA, probably originating from intercalated cell
asses, contain 1 subunits (Esmaeili et al., 2009). These
connections are important for extinction of conditioned fear
(Likhtik et al., 2008). Deficits in extinction learning have
been described for HAB rats (Muigg et al., 2008) and mice
(Yen et al., unpublished observation) and could be asso-
ciated with decreased 1 subunit expression.
CONCLUSION
We demonstrated differential alterations of the GABA-
ergic system in the amygdala of HAB mice, a model of
pathological trait anxiety. Expression of GAD65 and
GAD67 was highly up-regulated on mRNA as well as on
protein level, suggesting enhanced GABA synthesis and
release. Notably the increases in GAD65/67 and 2
subunit expression, but also that of subunits 1 and 2,
point towards a facilitated GABA transmission, aiming to
compensate the high-anxiety state of HAB mice. On the
other hand, the reduced expression of the 5 subunit in
the CEA and MEA may be part of the molecular mech-
anisms leading to the anxious phenotype of HAB mice.
A reduced number of 5 subunit containing receptors
may cause reduced tonic inhibition, favoring activation
of the amygdala even under non-stressful conditions as
illustrated by the increase in FosB expression. Both
mechanisms may be causatively related to the compen-
satory increase in GAD65 and GAD67 expression.
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